Benefits of Forskolin

Evidence-Based Benefits

• Body composition — Godard et al. (2005, n=30) found forskolin 250 mg × 2/day (10% extract) significantly decreased body fat percentage and fat mass while increasing lean body mass and testosterone in overweight men
• cAMP pathway — forskolin directly activates adenylyl cyclase, increasing intracellular cAMP, which activates protein kinase A and hormone-sensitive lipase for fat mobilization
• Testosterone increase — the Godard trial showed significant testosterone increase in the forskolin group, which may contribute to improved body composition

What the Research Says

Forskolin is a bioactive compound derived from the Coleus forskohlii plant, known for its ability to elevate cyclic AMP (cAMP) levels, which plays a role in various physiological processes. While its mechanism of action is well-understood, clinical evidence supporting its efficacy for weight management and other health outcomes remains limited.

In terms of body composition, one notable study by Godard et al. (2005) demonstrated significant improvements in body fat percentage and lean mass in overweight men following forskolin supplementation. However, a subsequent trial in women by Henderson et al. (2005) failed to replicate these findings, highlighting potential sex-specific differences in response.

Beyond weight management, Forskolin has shown promise in ophthalmology. A systematic review by Loskutova et al. (2019) highlighted its role in lowering intraocular pressure and improving visual outcomes in glaucoma patients when used as part of a multi-ingredient supplement. Similarly, Mutolo et al. (2016) reported enhanced visual function and reduced intraocular pressure in primary open-angle glaucoma patients after 12 months of treatment with a forskolin-containing supplement.

Despite these findings, the evidence base for Forskolin remains relatively small, and further research is needed to confirm its benefits across diverse populations and conditions. Its safety profile appears favorable, with no major adverse effects reported in clinical trials.

Related Conditions